Transcat Stock Downgraded by Zacks Research

Analysts cite concerns about the scientific instrument company's performance

Apr. 8, 2026 at 11:51am

Got story updates? Submit your updates here. ›

Zacks Research has downgraded shares of Transcat, a leading provider of calibration, laboratory, and metrology services, from a 'hold' rating to a 'strong sell' rating. The move comes as analysts express concerns about the company's financial outlook.

Why it matters

Transcat is a key player in the scientific instrument and measurement services industry, providing critical services to a wide range of sectors. The downgrade by a prominent research firm could signal broader challenges for the company and potentially impact investor confidence.

The details

In a research note issued on Monday, Zacks Research cited weaknesses in Transcat's recent financial performance as the basis for the downgrade. Separately, Weiss Ratings also maintained a 'sell (d+)' rating on the stock. Overall, the analyst consensus on Transcat is a 'hold', with one 'strong buy', two 'buy', and two 'sell' ratings.

  • Zacks Research downgraded Transcat on Monday, April 8, 2026.
  • Weiss Ratings reiterated a 'sell (d+)' rating on Transcat on December 29, 2025.

The players

Transcat

A leading provider of calibration, laboratory, and metrology services in North America, headquartered in Ronkonkoma, New York.

Zacks Research

A prominent investment research firm that provides analysis and ratings on publicly traded companies.

Weiss Ratings

An independent rating agency that provides financial strength ratings and research on stocks, mutual funds, and other investments.

Got photos? Submit your photos here. ›

The takeaway

The downgrade of Transcat by Zacks Research raises concerns about the company's financial performance and could impact investor sentiment. As a key player in the scientific instrument and measurement services industry, any challenges faced by Transcat could have broader implications for the sector.